IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $97 | -99.9% | 2,581 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $114,000 | -68.6% | 2,581 | -73.8% | 0.00% | -50.0% |
Q2 2022 | $363,000 | -12.7% | 9,851 | -12.5% | 0.00% | 0.0% |
Q1 2022 | $416,000 | +13.7% | 11,256 | -6.9% | 0.00% | 0.0% |
Q4 2021 | $366,000 | -99.2% | 12,092 | -99.1% | 0.00% | -99.1% |
Q3 2021 | $44,699,000 | -15.4% | 1,332,780 | +0.6% | 0.24% | -21.1% |
Q2 2021 | $52,837,000 | +60.1% | 1,324,611 | +80.5% | 0.30% | +33.6% |
Q1 2021 | $32,998,000 | +5.3% | 733,979 | +32.4% | 0.22% | -5.9% |
Q4 2020 | $31,331,000 | -7.9% | 554,172 | -22.7% | 0.24% | -25.7% |
Q3 2020 | $34,026,000 | -19.4% | 717,125 | +0.2% | 0.32% | -27.8% |
Q2 2020 | $42,209,000 | +33.2% | 715,880 | +6.8% | 0.44% | +6.2% |
Q1 2020 | $31,684,000 | +7.1% | 670,138 | +36.9% | 0.42% | +12.7% |
Q4 2019 | $29,579,000 | +13345.0% | 489,651 | +13213.0% | 0.37% | +12200.0% |
Q3 2019 | $220,000 | -24.7% | 3,678 | -19.0% | 0.00% | -25.0% |
Q2 2019 | $292,000 | -52.5% | 4,543 | -40.0% | 0.00% | -55.6% |
Q1 2019 | $615,000 | +203.0% | 7,577 | +101.9% | 0.01% | +125.0% |
Q4 2018 | $203,000 | +4.6% | 3,753 | 0.0% | 0.00% | +33.3% |
Q3 2018 | $194,000 | +24.4% | 3,753 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $156,000 | – | 3,753 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |